Stryker Corporation $SYK Shares Sold by Quilter Plc

Quilter Plc reduced its stake in Stryker Corporation (NYSE:SYK) by 1.5% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 98,599 shares of the medical technology company’s stock after selling 1,503 shares during the period. Quilter Plc’s holdings in Stryker were worth $39,009,000 at the end of the most recent reporting period.

Other hedge funds and other institutional investors have also recently bought and sold shares of the company. United Services Automobile Association acquired a new position in shares of Stryker in the first quarter worth about $2,857,000. Hendley & Co. Inc. increased its holdings in shares of Stryker by 60.3% in the 2nd quarter. Hendley & Co. Inc. now owns 14,018 shares of the medical technology company’s stock valued at $5,546,000 after acquiring an additional 5,274 shares during the last quarter. AXS Investments LLC raised its position in shares of Stryker by 13.7% during the 1st quarter. AXS Investments LLC now owns 8,827 shares of the medical technology company’s stock valued at $3,286,000 after acquiring an additional 1,062 shares in the last quarter. Two Point Capital Management Inc. bought a new stake in Stryker during the second quarter valued at $7,281,000. Finally, King Luther Capital Management Corp grew its position in shares of Stryker by 7.9% during the 2nd quarter. King Luther Capital Management Corp now owns 447,479 shares of the medical technology company’s stock valued at $177,036,000 after buying an additional 32,682 shares during the last quarter. 77.09% of the stock is owned by institutional investors and hedge funds.

Stryker Price Performance

Shares of NYSE SYK opened at $364.39 on Thursday. The business’s 50 day moving average price is $370.25 and its two-hundred day moving average price is $380.91. Stryker Corporation has a twelve month low of $329.16 and a twelve month high of $406.19. The company has a quick ratio of 1.06, a current ratio of 1.78 and a debt-to-equity ratio of 0.70. The company has a market cap of $139.35 billion, a PE ratio of 48.26, a price-to-earnings-growth ratio of 2.66 and a beta of 0.94.

Stryker (NYSE:SYK) last posted its earnings results on Thursday, October 30th. The medical technology company reported $3.19 earnings per share for the quarter, topping analysts’ consensus estimates of $3.13 by $0.06. The firm had revenue of $6.06 billion for the quarter, compared to analysts’ expectations of $6.04 billion. Stryker had a net margin of 12.25% and a return on equity of 23.94%. The company’s revenue was up 10.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $2.87 earnings per share. Stryker has set its FY 2025 guidance at 13.500-13.600 EPS. On average, analysts predict that Stryker Corporation will post 13.47 EPS for the current year.

Analysts Set New Price Targets

A number of research firms recently commented on SYK. Needham & Company LLC reiterated a “buy” rating and issued a $448.00 target price on shares of Stryker in a report on Friday, November 14th. BTIG Research reaffirmed a “buy” rating and issued a $410.00 target price on shares of Stryker in a research report on Friday, November 14th. Wall Street Zen raised Stryker from a “hold” rating to a “buy” rating in a research report on Saturday, October 18th. Sanford C. Bernstein reaffirmed an “outperform” rating on shares of Stryker in a research report on Monday, November 3rd. Finally, Weiss Ratings reiterated a “hold (c+)” rating on shares of Stryker in a research report on Thursday, November 13th. Thirteen investment analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. Based on data from MarketBeat.com, Stryker has an average rating of “Moderate Buy” and an average target price of $434.37.

Insider Activity

In other news, insider Viju Menon sold 500 shares of the company’s stock in a transaction on Monday, August 25th. The shares were sold at an average price of $390.61, for a total value of $195,305.00. Following the transaction, the insider owned 12,511 shares of the company’s stock, valued at approximately $4,886,921.71. This represents a 3.84% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, CAO William E. Berry, Jr. sold 1,953 shares of the business’s stock in a transaction that occurred on Friday, November 14th. The stock was sold at an average price of $365.49, for a total transaction of $713,801.97. Following the completion of the transaction, the chief accounting officer directly owned 2,833 shares of the company’s stock, valued at approximately $1,035,433.17. This represents a 40.81% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold 522,453 shares of company stock valued at $185,516,867 in the last ninety days. 5.90% of the stock is owned by company insiders.

About Stryker

Stryker Corporation operates as a medical technology company. The company operates through two segments, MedSurg and Neurotechnology, and Orthopaedics and Spine. The Orthopaedics and Spine segment provides implants for use in total joint replacements, such as hip, knee and shoulder, and trauma and extremities surgeries.